• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CorVel Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    6/1/26 5:05:42 PM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email
    8-K
    CORVEL CORP false 0000874866 0000874866 2026-05-27 2026-05-27
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 27, 2026

     

     

    CORVEL CORPORATION

    (Exact name of registrant as specified in charter)

     

     

     

    Delaware   000-19291   33-0282651
    (State or other jurisdiction
    of incorporation)
     

    (Commission

    file number)

      (IRS Employer
    Identification No.)

     

    5128 Apache Plume Road, Suite 400, Fort Worth, Texas   76109
    (Address of principal executive offices)   (Zip code)

    (817) 390-1416

    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    symbol(s)

     

    Name of each exchange
    on which registered

    Common Stock, par value $0.0001 per share   CRVL   The Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Transition of Chief Executive Officer and President; Appointment as Executive Chair

    Michael G. Combs, the Chief Executive Officer, President, and Chairman of the Board of Directors (the “Board”) of CorVel Corporation (the “Company”) is transitioning from his role as Chief Executive Officer and President of the Company, effective July 1, 2026, and has been appointed by the Board to serve as Executive Chair, effective as of the same date. In this role, Mr. Combs’ primary responsibilities will include (i) advising and supporting the inbound Chief Executive Officer and President during the leadership transition; (ii) assisting with the maintenance and growth of customer and strategic partner relationships; (iii) providing historical and operational context on key initiatives and decisions; and (iv) supporting long-range strategic planning. As consideration for serving as Executive Chair, Mr. Combs will receive a base salary of $25,000 per month and the continuation of health insurance benefits under the Company’s standard benefit plans.

    The Board wishes to express its appreciation to Mr. Combs for his many contributions over 34 years of dedicated service to the Company.

    Appointment of New Chief Executive Officer and President

    In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026. In this role, Ms. Scott will serve as the Company’s principal executive officer.

    Ms. Scott, age 49, has been with the Company for more than 26 years, joining the Company in 1999. Most recently, she served as Executive Vice President, Product and Corporate Services since September 2025. Prior to that, she served as Executive Vice President, Product from January 2025 to September 2025, Vice President, Network Solutions from July 2022 to January 2025, and Vice President, National Account Management from July 2017 to July 2022. Her prior positions with the Company include leadership roles in account management, network solutions, product development, and corporate services.

    In connection with her promotion to Chief Executive Officer and President, Ms. Scott’s annual base salary will be increased to $600,000. She will also be eligible for an annual cash bonus with a target of 75% of her base salary, and an opportunity to receive up to 100% of her base salary, based on the achievement of performance objectives established by the Compensation Committee. 75% of the bonus opportunity will be tied to the achievement of Company performance, while 25% will be tied to the achievement of individual MBOs. The bonus opportunity for fiscal year 2027 will be prorated based on the number of months for which she serves as Chief Executive Officer and President. Ms. Scott will also receive 25,000 stock options pursuant to the 2025 Stock Incentive Plan, which shall vest as to 25% of the underlying shares one year following the grant date, and as to the remaining 75% of the underlying shares in equal installments over the following 36 months. She will also continue to be eligible to participate in the Company’s standard employee benefit plans.

    There are no arrangements or understandings between Ms. Scott and any other person pursuant to which she was appointed as Chief Executive Officer and President. There are no family relationships between Ms. Scott and any director or executive officer of the Company. Except for her existing employment relationship with the Company, and the compensation arrangements arising in connection therewith, there are no relationships involving Ms. Scott that are required to be reported pursuant to Item 404(a) of Regulation S-K.

     

    Item 7.01

    Regulation FD Disclosure.

    On June 1, 2026, the Company issued a press release announcing the leadership transition discussed in Item 5.02 herein. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

    The information provided in this Item 7.01, and in Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be deemed

     


    incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as otherwise expressly set forth by specific reference in such filing.

     

    Item 9.01.

    Financial Statements and Exhibits.

     

      (d)

    Exhibits

     

    Exhibit
    No.

      

    Description

    99.1    Press Release, dated June 1, 2026.
    104    Cover Page Interactive Data File (embedded within the inline XBRL document).

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        CORVEL CORPORATION
    Dated: June 1, 2026     By:  

    /s/ Brian S. Nichols

        Name:   Brian S. Nichols
        Title:   Chief Financial Officer
    Get the next $CRVL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth

    FORT WORTH, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) today announced that it will mark its 35th anniversary as a publicly traded company listed on the Nasdaq Stock Market. Members of the company's executive leadership team, including Chairman, President, and CEO Michael Combs, will commemorate the milestone by ringing the Nasdaq opening bell in New York City. 35 Years of Strong Market Performance Fiscal year 2026 represents a defining moment for CorVel. The company's 35 years as a public organization reflect not only longevity, but the consistent execution of a strategy centered on technology investment, operational discipline, and a commitment to people.

    6/2/26 7:07:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair

    FORT WORTH, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- CorVel today announced that Sarah Scott will be appointed CEO and President, effective July 1, 2026, succeeding Michael G. Combs, who will transition to the role of Executive Chair. Mr. Combs has served as President since 2017 and CEO since 2019, leading the company through significant growth and strategic development. As Executive Chair, Mr. Combs will, among other things, advise and support Ms. Scott during the leadership transition and continue to advance the company's long-term vision and strategic priorities. Ms. Scott has served CorVel for more than 26 years and currently is the Executive Vice President, Product and Corporate Ser

    6/1/26 4:30:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $959 million, a 7% increase from $896 million during the fiscal year ended March 31, 2025. Earnings per share for the fiscal year ended March 31, 2026 were $2.14, up 17% compared to $1.83 during the fiscal year ended March 31, 2025. Revenues for the quarter were $249 million, an increase from $232 million in the March quarter of 2025. Earnings per share for the quarter were $0.61, up 20% compared to $0.51 in the same quarter of the prior year. Fourth Quarter Fiscal Year 2026

    5/20/26 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    SEC Filings

    View All

    CorVel Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - CORVEL CORP (0000874866) (Filer)

    6/1/26 5:05:42 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-K filed by CorVel Corp.

    10-K - CORVEL CORP (0000874866) (Filer)

    5/22/26 4:30:43 PM ET
    $CRVL
    Specialty Insurers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by CorVel Corp.

    SCHEDULE 13G/A - CORVEL CORP (0000874866) (Subject)

    3/26/26 5:42:49 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Vice President of Accounting Yoss Jennifer exercised 1,999 shares at a strike of $50.93 and sold $121,980 worth of shares (1,999 units at $61.02) (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    5/27/26 8:14:41 PM ET
    $CRVL
    Specialty Insurers
    Finance

    Chief Financial Officer Nichols Brian S. exercised 18 shares at a strike of $39.83 and covered exercise/tax liability with 13 shares (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    5/5/26 3:03:41 PM ET
    $CRVL
    Specialty Insurers
    Finance

    EVP - Risk Management Services Bertels Mark E. exercised 1,050 shares at a strike of $39.83 and covered exercise/tax liability with 830 shares, increasing direct ownership by 8% to 2,826 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    4/23/26 7:07:04 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair

    FORT WORTH, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- CorVel today announced that Sarah Scott will be appointed CEO and President, effective July 1, 2026, succeeding Michael G. Combs, who will transition to the role of Executive Chair. Mr. Combs has served as President since 2017 and CEO since 2019, leading the company through significant growth and strategic development. As Executive Chair, Mr. Combs will, among other things, advise and support Ms. Scott during the leadership transition and continue to advance the company's long-term vision and strategic priorities. Ms. Scott has served CorVel for more than 26 years and currently is the Executive Vice President, Product and Corporate Ser

    6/1/26 4:30:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly and fiscal earnings results on Wednesday, May 20, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Wednesday, May 20, 2026Time: 11:30 AM ETAccess: The

    5/12/26 7:02:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Tuesday, February 3, 2026Time: 11:30 AM ETAccess: The live

    1/20/26 8:05:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance